Susquehanna International Group, LLP Quotient LTD Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Shares

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$0.24 - $1.2 $20,477 - $102,388	-85,324 Reduced 27.41%	226,010 $54,000
Q4 2021 Feb 14, 2022	BUY	$1.89 - $3.12 $290,506 - $479,565	153,707 Added 97.51%	311,334 $806,000
Q3 2021 Nov 15, 2021	BUY	$2.34 - $3.77 $311,912 - $502,525	133,296 Added 547.84%	157,627 $369,000
Q2 2021 Aug 11, 2021	SELL	$3.48 - $4.45 $140,442 - $179,588	-40,357 Reduced 62.39%	24,331 $89,000
Q1 2021 May 17, 2021	BUY	$3.57 - $6.2 $73,681 - $127,961	20,639 Added 46.85%	64,688 $238,000
Q4 2020 Feb 16, 2021	BUY	$4.4 - $7.32 $1,707 - $2,840	388 Added 0.89%	44,049 $229,000
Q3 2020 Nov 16, 2020	BUY	$4.38 - $8.35 $3,009 - $5,736	687 Added 1.6%	43,661 $224,000
Q2 2020 Aug 14, 2020	BUY	$3.64 - $9.26 $77,542 - $197,265	21,303 Added 98.3%	42,974 $318,000
Q1 2020 May 15, 2020	SELL	$2.54 - $9.38 $112,110 - $414,014	-44,138 Reduced 67.07%	21,671 $86,000
Q4 2019 Feb 14, 2020	BUY	$7.07 - $9.51 $174,650 - $234,925	24,703 Added 60.1%	65,809 $626,000
Q3 2019 Nov 14, 2019	BUY	$7.77 - $11.26 $160,326 - $232,338	20,634 Added 100.79%	41,106 $319,000
Q2 2019 Aug 16, 2019	SELL	$7.91 - $10.25 $5,964 - $7,728	-754 Reduced 3.55%	20,472 $191,000
Q4 2018 Feb 14, 2019	BUY	$5.81 - $7.89 $50,233 - $68,216	8,646 Added 68.73%	21,226 $130,000
Q3 2018 Nov 14, 2018	SELL	$6.57 - $8.31 $602,574 - $762,159	-91,716 Reduced 87.94%	12,580 $95,000
Q2 2018 Aug 14, 2018	BUY	$3.93 - $8.93 $409,883 - $931,363	104,296 New	104,296 $837,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.